Water Loss in the Skin of Pediatric Eczema Patients


Trial Objective

Water Loss in the Skin of Pediatric Eczema PatientsResearchers are studying how much water is lost in the skin of pediatric atopic dermatitis patients (eczema) before and after using the medication dupilumab, the generic form of Dupixent®. Pediatric patients without eczema are needed, too. Patient’s skin will be tested through the use of skin tape, a circular, slightly sticky disk that is placed on the skin and removed to collect skin cell samples.


Active Clinical Trials Currently Recruiting

Who Can Participate

Pediatric patients with moderate to severe atopic dermatitis (eczema) and those without eczema.

Age: 6-12    Gender: Any Gender

Estimated Time Commitment

Up to 12 visits over 8 months

Including a 4-month treatment period for atopic dermatitis (eczema) participants.

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Shannon Garcia

Shannon Garcia

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.

 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: